Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 69,821 | 11,565 | 84 | 232 | 46 |
| Cost of Goods | 49,668 | 9,706 | 32 | 25 | 22 |
| Gross Profit | 20,153 | 1,859 | 52 | 207 | 23 |
| Operating Expenses | 39,700 | 28,434 | 9,317 | 10,671 | 4,737 |
| Operating Income | -18,878 | -25,869 | -9,234 | -10,439 | -4,691 |
| Interest Expense | 481 | 23 | 12 | 22 | 1,381 |
| Other Income | 513 | -16 | 3 | 15 | 20 |
| Pre-tax Income | -18,846 | -25,908 | -9,242 | -10,446 | -6,051 |
| Income Tax | 551 | 42 | N/A | N/A | N/A |
| Net Income Continuous | -19,397 | -25,950 | -9,242 | -10,446 | -6,051 |
| Minority Interests | 3,909 | 221 | N/A | N/A | N/A |
| Net Income | $-23,306 | $-26,171 | $-9,242 | $-10,446 | $-6,051 |
| EPS Basic Total Ops | -689.66 | -3,658.17 | -2,293.85 | -4,767.62 | -6,641.68 |
| EPS Basic Continuous Ops | -563.23 | -2,988.22 | -2,287.67 | -4,768.52 | -6,646.44 |
| EPS Diluted Total Ops | -689.66 | -3,658.17 | -2,293.85 | -4,767.62 | -6,641.68 |
| EPS Diluted Continuous Ops | -563.23 | -2,988.22 | -2,287.67 | -4,768.52 | -6,646.44 |
| EBITDA(a) | $-12,903 | $-25,149 | $-9,118 | $-10,385 | $-4,664 |